Punch & Associates Investment Management Inc. Has $4.58 Million Stake in UFP Technologies, Inc. $UFPT

Key Points

• Punch & Associates Investment Management Inc. has decreased its stake in UFP Technologies, Inc. by 39.0%, owning 22,700 shares after selling 14,500 shares in the first quarter.
• Wall Street analysts have a positive outlook, with Lake Street Capital raising its price target for UFP Technologies from $252.00 to $289.00 and giving it a "buy" rating.
• UFP Technologies reported quarterly earnings of $2.50 per share, exceeding estimates, and achieved revenue of $151.18 million, a 37.2% increase year-over-year.

Punch & Associates Investment Management Inc. cut its position in shares of UFP Technologies, Inc. (NASDAQ:UFPT - Free Report) by 39.0% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 22,700 shares of the industrial products company's stock after selling 14,500 shares during the period. Punch & Associates Investment Management Inc. owned 0.29% of UFP Technologies worth $4,579,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the company. Lazard Asset Management LLC bought a new position in UFP Technologies in the 4th quarter worth approximately $84,000. State of Wyoming raised its holdings in shares of UFP Technologies by 34.7% in the 1st quarter. State of Wyoming now owns 365 shares of the industrial products company's stock worth $74,000 after buying an additional 94 shares in the last quarter. Park Square Financial Group LLC acquired a new stake in shares of UFP Technologies in the 4th quarter valued at $107,000. CreativeOne Wealth LLC acquired a new position in UFP Technologies in the first quarter valued at about $203,000. Finally, Dakota Wealth Management bought a new stake in UFP Technologies during the 1st quarter worth approximately $204,000. Institutional investors own 87.28% of the company's stock.

Wall Street Analyst Weigh In

Separately, Lake Street Capital boosted their target price on shares of UFP Technologies from $252.00 to $289.00 and gave the stock a "buy" rating in a research note on Wednesday, August 6th. One investment analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, UFP Technologies presently has an average rating of "Moderate Buy" and a consensus target price of $289.00.

UFP Technologies Stock Down 0.8%

Shares of UFP Technologies stock traded down $1.73 during trading hours on Tuesday, reaching $204.06. 106,649 shares of the company's stock were exchanged, compared to its average volume of 93,410. The stock has a market cap of $1.57 billion, a P/E ratio of 23.65 and a beta of 1.20. The company has a 50 day moving average of $226.37 and a two-hundred day moving average of $223.87. The company has a current ratio of 2.77, a quick ratio of 1.53 and a debt-to-equity ratio of 0.39. UFP Technologies, Inc. has a fifty-two week low of $178.26 and a fifty-two week high of $366.41.

UFP Technologies (NASDAQ:UFPT - Get Free Report) last issued its earnings results on Monday, August 4th. The industrial products company reported $2.50 earnings per share for the quarter, topping analysts' consensus estimates of $2.25 by $0.25. The business had revenue of $151.18 million for the quarter, compared to the consensus estimate of $151.55 million. UFP Technologies had a net margin of 11.40% and a return on equity of 21.54%. The firm's revenue for the quarter was up 37.2% on a year-over-year basis. During the same period in the previous year, the company earned $1.86 earnings per share.

UFP Technologies Company Profile

UFP Technologies, Inc designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners.